SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-042078
Filing Date
2021-10-29
Accepted
2021-10-29 19:23:01
Documents
1
Period of Report
2021-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6032
  Complete submission text file 0000899243-21-042078.txt   7413
Mailing Address 85 BOLTON STREET CAMBRIDGE MA 02140
Business Address 85 BOLTON STREET CAMBRIDGE MA 02140 (617)500-8864
Aura Biosciences, Inc. (Issuer) CIK: 0001501796 (see all company filings)

IRS No.: 320271970 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O KARYOPHARM THERAPEUTICS INC. 85 WELLS AVENUE, SECOND FLOOR NEWTON MA 02459
Business Address
Primiano Christopher Brett (Reporting) CIK: 0001603510 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40971 | Film No.: 211364817